{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 18,
        "end": 21
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 34,
        "end": 45
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 50,
        "end": 59
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 144,
        "end": 157
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 76,
        "end": 88
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "17919354_6",
  "text": "The pertinence of HFE mutations , anastrozole and tamoxifen treatment , and chemotherapy to the development and management of PCT in women with breast cancer is discussed ."
}
